Surveys show that about 15 percent of adults in the United States have diabetes and more than 40 percent are obese. By 2023, about 1.7 percent of people in the United States will have been prescribed Semaglutide. Add in overweight people in other countries who are using Semaglutide, as well as some overweight people who buy Semaglutide drugs out of …